NEWS
Oct 14, 2022
Calciscon T50 Newsletter - October 2022
Two new publications add to the growing evidence that T50 and calciproteins particles are the carrier of Phosphate Toxicity, rather than soluble phosphate. In a cohort of 28 dialysis patients, administration of the phosphate binder Velphoro® (sucroferric oxyhydroxide) led to a redution in levels of calciproteins particles, improvement of the T50, and amelioration of inflammation.
© 2022 by CALCISCON | Privacy Policy